急诊静脉溶栓治疗急性心肌梗死的临床分析

目的探讨急诊静脉溶栓治疗急性心肌梗死（AMI）的疗效及预后。方法选择36例急诊AMI患者应用尿激酶静脉溶栓治疗，判断再通率，观察急性期心脏事件发生情况。结果（1）36例AMI患者中获得冠脉再通23例，再通率为63．9％；其中发病≤6h溶栓再通率21／27（77．8％），发病〉6h溶栓再通率2／9（22．2％），两组相比差异有统计学极显著意义（P〈0．01）。结论急诊静脉溶栓治疗AMI是切实可行的一种有效方法，使更多的AMI病人及早赢得时间，得到有效治疗，挽救更多病人生命。

Clinical analysis on emergency intravenous thrombolytic therapy for acute myocardial infarction

Objective To study the efficacy and prognosis of emergency intravenous thrombolytic therapy for acute myocardial infarction （ AMI ）. Methods Thirty-six cases of AMI in emergency were treated by intravenous thrombolytie therapy with urokinase. The reeanalization rate of cases of AMI were determined and the occurrence of cardiac events in acute phase were observed. Results In all 36 cases of AMI, there were 23 cases obtained the coronary recanalization, the recanalization rate was 63.9%. Of 36 cases 27 cases were treated with thrombolysis within 6h of incidence, 21 cases obtained the coronary recanalization, the recanalization rate was 21/27 （77.8%）. 9 cases were treated greater than 6h of incidence the thrombolytic recanalization rate was 2 / 9 （22. 2% ）. There was significant differences in the thrombolytie recanalization rate between two groups （P 〈 0. 05 ）. Conclusion Emergency intravenous thrombolytic therapy for AMI is a timely and effective practical ways. The patients of AMI will be treated early, and more patients were be successfully salvaged.